0
纽约州长:4月20日发布使用羟氯喹治疗新冠肺炎实验报告财联社4月13日讯,纽约州州长科莫表示,目前纽约州有大约2000名新冠病毒感染者加入了医院使用羟氯喹治疗实验。这是配合联邦政府进行的用药实验,目前实验只开展了了大约1周或者10天时间,从医护人员反馈情况来看,比较乐观,但正式实验报告要4月20日发布。
0
主持氯喹治疗的马赛大学医院研究所教授迪迪埃拉乌尔特周一表示,测试显示氯喹的治疗效果惊人,四分之三的患者用药六天内显示药到病除。
不过,FDA负责人哈恩称,该药物还需要进行临床试验。他表示:“总统指示我们仔细研究这一药物,以确定是否可以扩大这一药物的治疗范围,实际了解这是否有益于患者。”
0
美国食品药品管理局(FDA):当前,优先审查新递交的关于磷酸氯喹和硫酸羟氯喹新药申请,发布具体产品的指导原则,以支持关于这两种药品的仿制药研发。
0
美国《新闻周刊》报道,瑞典西约塔兰省的几家医院已经停止对新冠肺炎患者使用抗疟疾药氯喹,因为该药物引起了严重的副作用,包括抽筋和周边视力丧失等
0
厉害了啊。
1
Science杂志报道4万医护人员参与的氯喹/羟氯喹预防新冠病毒感染临床实验将在亚洲非洲欧洲三地开展
The international study is one of several in preparation or underway that seek to use drugs for what is called pre-exposure prophylaxis (PrEP), a strategy already widely used against HIV. The Bill & Melinda Gates Foundation is funding plans for another huge study that will test the same two drugs in Africa, North America, and Europe. Separate studies of the same drugs are planned or underway in the United States, Australia, Canada, Spain, and Mexico. 美国,澳大利亚,加拿大,西班牙和墨西哥也即将或者正在进行使用氯喹/羟氯喹预防新冠病毒感染的临床实验。Researchers are also considering other potential preventives, including nitazoxanide, a drug used to treat parasitic infections, and the antibody-laden serum from people who have recovered from an infection.
In White’s proposed trial, health care workers in Asia will be randomized to take chloroquine or a placebo for 3 months, while hydroxychloroquine will be used in Africa and Europe. 亚洲的医护人员将服用氯喹或者安慰剂三个月的时间, 非洲和欧洲的医护人员将服用羟氯喹。 Participants have to take their temperature twice a day and report it, along with any symptoms, through an app or a website. The researchers will compare the number of symptomatic and asymptomatic infections in both groups, as well as the severity and duration of illness in those who become infected.
In the Spanish trial, people with symptoms who test positive for COVID-19 are treated with the HIV combination drug darunavir/cobicistat plus hydroxychloroquine. Anyone known to have spent more than 15 minutes with them in the previous 5 days is treated with hydroxychloroquine for 4 days. 接触确诊新冠病毒病人超过15分钟的人将服用4天的硫酸羟氯喹作为预防手段。 Patients in a control group and their contacts receive no drug—there was no time to prepare an appropriate placebo, Mitjà says.
Some countries aren’t waiting for the new trials. India, for instance,has already recommended hydroxychloroquinefor health care workers caring for suspected or confirmed COVID-19 cases as well as patients’ household contacts; Bangladesh has a similar policy. (White says he had to exclude both countries from the international study as a result.) 有些国家已经等不及这个临床实验,例如印度,直接就向医护人员推荐使用硫酸羟氯喹预防新冠病毒感染。
0
300194连板
0
炒股炒成,
百事通才对!继续对任何事情都有理解力判断力
0
知道这药2个月了,股市资金没反应,等发酵后再跟
0
有药了就好,股票涨不涨不重要。